Environmental Social Governance
“As a purpose-driven company, I believe the onus is on us to lead by example and create the just and equitable industry in which we seek to operate. Fundamental to this is developing and articulating our clear commitment to environmental, social, and governance (ESG). With that, I am pleased to share with you our inaugural ESG report.” David Klein, CEO Canopy Growth
In this inaugural ESG report we describe our progress from January 1, 2020 to December 31, 2020, as well as qualitative details on some key activities that occurred in 2021.
Throughout the report, we guide readers to additional sources of information and it is our intention to continually review the Company’s ESG progress. We plan to publish our next report in 2022.
To download the report click here.
Committed to Veterans
Canopy Growth is proud to support veterans through breaking down barriers to access through our Spectrum Therapeutics Veteran support program. The program makes becoming a medical cannabis patient easier than ever while also eliminating some of the financial barriers that veterans often face. Learn more about our veteran support program here.
Through Spectrum Therapeutics – our global medical arm, we proudly work with Wounded Warriors Canada, a national mental health organization that provides programming to Veterans, First Responders, and their families with national group-based trauma therapy programs and expanded program offerings to mitigate the increased mental health impacts of COVID-19. We’re also proud to support Team Rubicon, a charitable organization that helps Veterans mobilize and apply their skills to aid communities affected by disasters and humanitarian crises.
Supporting Connectivity in Long-Term Care Facilities
Some seniors are very open to medical cannabis, yet they often hit roadblocks under the traditional doctor/caregiver-patient approach. This brought Canopy Growth and Spectrum Therapeutics to launch the largest study to date on cannabis use in long-term care (LTC).
The challenge for both families and caregivers is sorting facts and evidence in an area that has limited clinical investigation. Medical cannabis is coming into the sector like a wave, and in response, we have enrolled more than 500 LTC residents in a study that aims to improve awareness in the LTC space on the potential uses of medical cannabis to displace other, potentially less-desirable therapeutics for both pain, sleep and behavioural and psychological symptoms of dementia in long-term care settings.
To help residents feel more connected to their family and friends during the pandemic, Spectrum Therapeutics sent a total of 57 iPads and iPad stands to 21 long term care homes participating in the study. The donation is a step in the right direction as we build our legacy of making a positive impact in the communities we operate.
Support for Criminal Justice Reforms
National Expungement Works
Over the past three years, Canopy Growth has supported National Expungement Works (N.E.W.), bringing expungement clinics and forms of legal relief to events across 30 cities in the US. We stand united with individuals fighting for social equality and continue to support these organizations as they advance their interests.
Americans for Safe Access
Canopy Growth is proud to have supported Americans for Safe Access, one of the largest medical cannabis patient organizations, in sending over a dozen patients from across the world to the United Nations’ Commission on Narcotic Drugs (CND) in Vienna, Austria. Patients participated in events, met with delegates regarding the importance of safe medical cannabis access and watched the Canadian deliberations.
Canopy has partnered with the British Columbia Ministry of Mental Health and Addictions to donate $2.5 million to the University of British Columbia (UBC) and the British Columbia Centre on Substance Use (BCCSU) to fund the Canopy Growth Professorship of Cannabis Science. The professorship is held by Dr. M-J Milloy and examines the potential utility of cannabis in addressing the overdose crisis and the potential benefits of cannabis as a legitimate therapeutic treatment for substance use. Read more about recent research here.
Medical Cannabis Canada Patient Survey
Canopy Growth and Spectrum Therapeutics contributed an unrestricted grant to support Medical Cannabis Canada (MCC), a leading, volunteer-run medical cannabis patient organization, to complete their first national patient survey. MCC is leveraging these insights to advocate on behalf of patients with key stakeholders for the importance of a distinct medical stream, as well as where barriers can be reduced to ensure reasonable access for all Canadians.
Canadian Aids Society – Clinical Practice Guidelines
Canopy Growth’s multi-year partnership with Canadian Aids Society (one of the first patient groups to champion medical cannabis access for patients in the early 2000s), has brought together 14 physicians, researchers, and patients to develop evidence-informed clinical practice guidelines for the use of medical cannabis to manage chronic pain and associated symptoms. Read the guidelines here.